A health worker administers the malaria vaccine Oxford-Serum R21 to a child in Abidjan, Ivory Coast, 15 July 2024 ...

New infant-friendly formulation closes a critical treatment gap for the youngest children, with support from African-led trials and global partners.Addis Ababa, 16 August 2025 - The Africa Centres for ...

First Malaria Drug for InfantsThe Africa Centres for Disease Control and Prevention (Africa CDC) welcomed the approval of the first malaria treatment designed for newborns and infants under five ...

The Africa Centres for Disease Control and Prevention (Africa CDC) applauded Nigeria for its role in the trials in a ...

From Jan. 1 to Aug. 13, 2025, the continent recorded 97,144 suspected mpox cases, 29,849 confirmed cases, and 593 deaths across 24 AU member states.

Nigeria has joined seven other African nations in pioneering a clinical trial that has resulted in the approval of the first ...

As international funding rapidly recedes, African countries — among those with the highest new HIV infection rates are ...

Nigeria has been named among eight African countries involved in the clinical trial of the world’s first malaria treatment ...

A year ago, on Aug. 14, 2024, the World Health Organization declared mpox a Public Health Emergency of International Concern.

Mpox remains a serious public health challenge in Africa. In the past year, 28 African countries have been affected, with ...

For the first time, newborns and infants weighing less than five kilogrammes will have access to a newly approved malaria treatment, whose clinical trials were conducted in eight African countries.

A year ago, on August 14, 2024, the World Health Organization declared mpox a Public Health Emergency of International ...